📄 Read our new white paper: ‘ The Case for Smarter GLP-1 Utilization: Cost, Coverage, and Clinical Outcomes '
Details
MyPhenome
Contact
📄 Read our new white paper: ‘ The Case for Smarter GLP-1 Utilization: Cost, Coverage, and Clinical Outcomes '

Evidence

Featured

Phenotyping

Genetic and physiological insights into satiation variability predict responses to obesity treatment

Lizeth Cifuentes, Diego Anazco, Timothy O’Connor, Maria Daniela Hurtado, Wissam Ghusn, Alejandro Campos, Sima Fansa, Alison McRae, Sunil Madhusudhan, Elle Kolkin, Michael Ryks, William S. Harmsen, Serban Ciotlos, Barham K. Abu Dayyeh, Donald D. Hensrud, Michael Camilleri, Andres Acosta
Article
PDF
All
Lifestyle
Medications
Phenotyping
Procedures

Publications

Medications

Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study

Andres Acosta, Michael Camilleri, Duane Burton, Jessica O'Neill, Deborah Eckert, Paula Carlson, Alan R Zinsmeister
Article
PDF
Medications

Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial

Houssam Halawi, Disha Khemani, Deborah Eckert, Jessica O'Neill, Hoda Kadouh, Karen Grothe, Matthew M Clark, Duane D Burton, Adrian Vella, Andres Acosta, Alan R Zinsmeister, Michael Camilleri
Article
PDF
Medications

Gastrointestinal traits: individualizing therapy for obesity with drugs and devices

Michael Camilleri, Andres Acosta
Article
PDF
Medications

Pharmacogenomics of Medication-Induced Weight Gain and Antiobesity Medications

Sneha Singh, Maria L. Ricardo-Silgado, Suzette J. Bielinski, Andres Acosta
Article
PDF

White Papers

Medications

The Case for Smarter GLP-1 Utilization: Cost, Coverage, and Clinical Outcomes with MyPhenomeRx

Phenomix Sciences
Article
PDF
© 2026 Phenomix Sciences, All Rights Reserved.
Contact
|
Terms of Service
|
Privacy Policy
|
FCOI
‍